Fortress Biotech Inc Stock, NASDAQ:FBIO
2 Gansevoort Street, 9th floor, New York, New York 10014
United States of America
Number of Employees: 111
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the following Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded on June 28, 2006 and is headquartered in New York, NY.